By analyzing ST-seq data from HCC patients treated with TKIs in combination with PD-1 inhibitors, we observed that the scores of TP, TME-RPS-related genes, and XPO1+Epithelial genes were significantly increase in the responsive group. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.